For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

We use cookies to make our site as useful as possible.

Our Cookie Policy explains how you can opt-out of the cookies we use.

If you continue without changing your cookie settings, we'll assume you’re happy with this.

Continue Continue

United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Diagnostic & Therapeutic Solutions
    Custom solutions & partnerships

    Custom antibody development and commercial partnerships to advance your diagnostic and therapeutic discovery.

    Create custom solutions with us

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

Supporting our customers and employees during the COVID-19 pandemic. Read more

  1. Link

    apc-ctla4-antibody-bni3-ab210253.pdf

  1. Send me a copy of this email
    I agree to the terms and conditions.
Immunology Adaptive Immunity T Cells Cytotoxic Cells
Share by email

APC Anti-CTLA4 antibody [BNI3] (ab210253)

  • Datasheet
Submit a review Submit a question

Product price, shipping and contact information

Currently unavailable

Sorry, we can't display this right now.

Please contact us to place your order, or try again later.

 

Loading size & price…

 

Shipping and order information

Abpromise

Guaranteed product quality, expert customer support.

Find out more.

Flow Cytometry - APC Anti-CTLA4 antibody [BNI3] (ab210253)

    Key features and details

    • APC Mouse monoclonal [BNI3] to CTLA4
    • Suitable for: Flow Cyt
    • Reacts with: Human
    • Conjugation: APC. Ex: 645nm, Em: 660nm
    • Isotype: IgG2a

    You may also be interested in

    Protein
    Product image
    Recombinant human CTLA4 protein (Fc Chimera Active) (ab215007)
    Primary
    Product image
    Anti-PD1 (phospho Y248) antibody [EPR19821] - BSA and Azide free (ab234960)
    Primary
    Product image
    Anti-CTLA4 antibody [CAL49] - BSA and Azide free (ab251599)

    View more associated products

    Overview

    • Product name

      APC Anti-CTLA4 antibody [BNI3]
      See all CTLA4 primary antibodies
    • Description

      APC Mouse monoclonal [BNI3] to CTLA4
    • Host species

      Mouse
    • Conjugation

      APC. Ex: 645nm, Em: 660nm
    • Tested applications

      Suitable for: Flow Cytmore details
    • Species reactivity

      Reacts with: Human
      Predicted to work with: Baboon, Cynomolgus monkey, Rhesus monkey
    • Immunogen

      The details of the immunogen for this antibody are not available.

    • Positive control

      • Human peripheral blood lymphocytes.
    • General notes

      This is a neutralizing antibody.

      Reproducibility is key to advancing scientific discovery and accelerating scientists’ next breakthrough.

      Abcam is leading the way with our range of recombinant antibodies, knockout-validated antibodies and knockout cell lines, all of which support improved reproducibility.

      We are also planning to innovate the way in which we present recommended applications and species on our product datasheets, so that only applications & species that have been tested in our own labs, our suppliers or by selected trusted collaborators are covered by our Abpromise™ guarantee.

      In preparation for this, we have started to update the applications & species that this product is Abpromise guaranteed for.

      We are also updating the applications & species that this product has been “predicted to work with,” however this information is not covered by our Abpromise guarantee.

      Applications & species from publications and Abreviews that have not been tested in our own labs or in those of our suppliers are not covered by the Abpromise guarantee.

      Please check that this product meets your needs before purchasing. If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, as well as customer reviews and Q&As.

    Properties

    • Form

      Liquid
    • Storage instructions

      Shipped at 4°C. Store at +4°C. Store In the Dark.
    • Storage buffer

      pH: 7.20
      Preservative: 0.09% Sodium azide
      Constituents: 0.12% Monobasic dihydrogen sodium phosphate, 0.1% Gelatin, 0.87% Sodium chloride
    • Concentration information loading...
    • Purity

      Affinity purified
    • Purification notes

      Purified from tissue culture supernatant and conjugated under optimal conditions, with unreacted dye removed from the preparation.
    • Clonality

      Monoclonal
    • Clone number

      BNI3
    • Isotype

      IgG2a
    • Light chain type

      kappa
    • Research areas

      • Immunology
      • Adaptive Immunity
      • T Cells
      • Cytotoxic Cells
      • Immunology
      • Adaptive Immunity
      • T Cells
      • CD
      • Immunology
      • Immune System Diseases
      • Autoimmune
      • Stem Cells
      • Hematopoietic Progenitors
      • Lymphoid
      • T Lymphocytic Lineage
      • Immunology
      • Adaptive Immunity
      • Regulatory T Cells

    Associated products

    • Alternative Versions

      • Anti-CTLA4 antibody [BNI3] (ab19792)
      • PE Anti-CTLA4 antibody [BNI3] (ab210254)
    • Isotype control

      • APC Mouse IgG2a [B12/8] - Isotype Control (ab91364)
    • Recombinant Protein

      • Recombinant human CTLA4 protein (Fc Chimera Active) (ab215007)

    Applications

    Our Abpromise guarantee covers the use of ab210253 in the following tested applications.

    The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

    Application Abreviews Notes
    Flow Cyt Use 5µl for 105-8 cells.

    in 100 μl volume.

    Target

    • Function

      Inhibitory receptor acting as a major negative regulator of T-cell responses. The affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28.
    • Tissue specificity

      Widely expressed with highest levels in lymphoid tissues. Detected in activated T-cells where expression levels are 30- to 50-fold less than CD28, the stimulatory coreceptor, on the cell surface following activation.
    • Involvement in disease

      Genetic variation in CTLA4 influences susceptibility to systemic lupus erythematosus (SLE) [MIM:152700]. SLE is a chronic, inflammatory and often febrile multisystemic disorder of connective tissue. It affects principally the skin, joints, kidneys and serosal membranes. SLE is thought to represent a failure of the regulatory mechanisms of the autoimmune system.
      Note=Genetic variations in CTLA4 may influence susceptibility to Graves disease, an autoimmune disorder associated with overactivity of the thyroid gland and hyperthyroidism.
      Genetic variation in CTLA4 is the cause of susceptibility to diabetes mellitus insulin-dependent type 12 (IDDM12) [MIM:601388]. A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical fetaures are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.
      Genetic variation in CTLA4 is the cause of susceptibility to celiac disease type 3 (CELIAC3) [MIM:609755]. It is a multifactorial disorder of the small intestine that is influenced by both environmental and genetic factors. It is characterized by malabsorption resulting from inflammatory injury to the mucosa of the small intestine after the ingestion of wheat gluten or related rye and barley proteins. In its classic form, celiac disease is characterized in children by malabsorption and failure to thrive.
    • Sequence similarities

      Contains 1 Ig-like V-type (immunoglobulin-like) domain.
    • Post-translational
      modifications

      N-glycosylation is important for dimerization.
      Phosphorylation at Tyr-201 prevents binding to the AP-2 adapter complex, blocks endocytosis, and leads to retention of CTLA4 on the cell surface.
    • Cellular localization

      Cell membrane. Exists primarily an intracellular antigen whose surface expression is tightly regulated by restricted trafficking to the cell surface and rapid internalisation and.
    • Target information above from: UniProt accession P16410 The UniProt Consortium
      The Universal Protein Resource (UniProt) in 2010
      Nucleic Acids Res. 38:D142-D148 (2010) .

      Information by UniProt
    • Database links

      • Entrez Gene: 1493 Human
      • Omim: 123890 Human
      • SwissProt: P16410 Human
      • Unigene: 247824 Human
      • Alternative names

        • ALPS5 antibody
        • CD 152 antibody
        • CD antibody
        • CD152 antibody
        • CD152 antigen antibody
        • CD152 isoform antibody
        • Celiac disease 3 antibody
        • CELIAC3 antibody
        • CTLA 4 antibody
        • CTLA-4 antibody
        • CTLA4 antibody
        • CTLA4_HUMAN antibody
        • Cytotoxic T cell associated 4 antibody
        • Cytotoxic T lymphocyte antigen 4 antibody
        • Cytotoxic T lymphocyte associated 4 antibody
        • Cytotoxic T lymphocyte associated 4, soluble isoform, included antibody
        • Cytotoxic T lymphocyte associated antigen 4 antibody
        • Cytotoxic T lymphocyte associated antigen 4 short spliced form antibody
        • Cytotoxic T lymphocyte associated protein 4 antibody
        • Cytotoxic T lymphocyte associated serine esterase 4 antibody
        • Cytotoxic T lymphocyte protein 4 antibody
        • Cytotoxic T-lymphocyte protein 4 antibody
        • Cytotoxic T-lymphocyte-associated antigen 4 antibody
        • GRD4 antibody
        • GSE antibody
        • ICOS antibody
        • IDDM12 antibody
        • insulin-dependent diabetes mellitus 12 antibody
        • Ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4 antibody
        • OTTHUMP00000216623 antibody
        see all

      Images

      • Flow Cytometry - APC Anti-CTLA4 antibody [BNI3] (ab210253)
        Flow Cytometry - APC Anti-CTLA4 antibody [BNI3] (ab210253)

        Flow Cytometrical analysis of Human peripheral blood lymphocytes labeling CTLA4 using 5 μL (0.125 μg) ab210253 (solid line) or 0.125 μg Allophycocyanin Mouse IgG2a isotype control (dashed line). Right panel: CD4+, CD45RO+ cells. Left pane:  CD4+, CD45RO- cells.

      Protocols

      • Flow cytometry protocols

      Click here to view the general protocols

      Datasheets and documents

      • Datasheet
    • References (0)

      Publishing research using ab210253? Please let us know so that we can cite the reference in this datasheet.

      ab210253 has not yet been referenced specifically in any publications.

      Customer reviews and Q&As

      Show All Reviews Q&A
      Submit a review Submit a question

      There are currently no Customer reviews or Questions for ab210253.
      Please use the links above to contact us or submit feedback about this product.

      Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
      For licensing inquiries, please contact partnerships@abcam.com

      Get resources and offers direct to your inbox Sign up
      A-Z by research area
      • Cancer
      • Cardiovascular
      • Cell biology
      • Developmental biology
      • Epigenetics & Nuclear signaling
      • Immunology
      • Metabolism
      • Microbiology
      • Neuroscience
      • Signal transduction
      • Stem cells
      A-Z by product type
      • Primary antibodies
      • Secondary antibodies
      • Biochemicals
      • Isotype controls
      • Flow cytometry multi-color selector
      • Kits
      • Loading controls
      • Lysates
      • Peptides
      • Proteins
      • Slides
      • Tags and cell markers
      • Tools & Reagents
      Help & support
      • Support
      • Make an Inquiry
      • Protocols & troubleshooting
      • Placing an order
      • RabMAb products
      • Biochemical product FAQs
      • Training
      • Browse by Target
      Company
      • Corporate site
      • Investor relations
      • Company news
      • Careers
      • About us
      • Blog
      Events
      • Tradeshows
      • Conferences
      International websites
      • abcam.cn
      • abcam.co.jp

      Join with us

      • LinkedIn
      • facebook
      • Twitter
      • YouTube
      • Terms of sale
      • Website terms of use
      • Cookie policy
      • Privacy policy
      • Legal
      • Modern slavery statement
      © 1998-2021 Abcam plc. All rights reserved.